Insights : sector - Osborne Clarke

Life Sciences and Healthcare

Learn more about this sector

Article list

Life Sciences and Healthcare

Court of Appeal overturns English Patents Court and grants interim injunction to prevent 'at risk' generic launch

Patents Court found wrong to hold damages would be an adequate remedy for AstraZeneca

29/04/2025

Read time 6m

Life Sciences and Healthcare

EU court issues significant decision on pharma-device 'borderline' product case

European ruling clarifies the definition of pharmacological action for health products

24/04/2025

Read time 4m

Intellectual property

European Council adopts negotiating mandate on patents for gene-edited plants

EU moves closer to regulatory change for gene-edited plants but still a long way to go

16/04/2025

Read time 4m

Life Sciences and Healthcare

EU proposes tailored approach to streamline biosimilar development

New EMA reflection paper signals a step change in biosimilar approval, reducing requirements while maintaining standards

08/04/2025

Read time 3m

Life Sciences and Healthcare

New regulations signal next step for precision bred plants in England

Government sets out new simplified authorisation process for precision bred organisms

08/04/2025

Read time 3m

Regulatory and compliance

How is the UK regulatory landscape set to change?

The government is driving a pro-growth agenda, leading to transformative changes in regulatory operations

27/03/2025

Read time 12m

Life Sciences and Healthcare

EU set to upgrade medtech and diagnostics regulations

Commission-led targeted evaluation and reforms to the EU medical devices regulatory framework are reshaping the sector

25/03/2025

Read time 6m

Life Sciences and Healthcare

EU regulatory activity is driving comprehensive reforms for pharma in 2025

The European Union's regulatory framework for the pharmaceutical sector is undergoing significant transformations

25/03/2025

Read time 5m

Commercial

New EU packaging and waste regulation comes into force to promote sustainability

Effective implementation of this advance for the circular economy now depends on national legislation by Member States

25/02/2025

Read time 3m

Regulatory and compliance

Court of Appeal rules on duty to clarify tender submissions with bidders in UK public procurement

Decision explains when contracting authorities must clarify incomplete or ambiguous information in tender submissions

21/02/2025

Read time 7m

Life Sciences and Healthcare

The fight against counterfeit medicines in Italy

The Italian legislative decree implementing Regulation (EU) 2016/161 enters into force

20/02/2025

Read time 3m

Life Sciences and Healthcare

The Future of Cannabis in Germany: What to Expect After the 2025 Elections

The German cannabis industry is transforming rapidly. The introduction of the Cannabis Act (CanG) in April 2024 brought significant changes...

19/02/2025

Read time 3m

Regulatory and compliance

New NPPS sets out 'value for money' message for UK public procurement

Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability

14/02/2025

Read time 4m

Life Sciences and Healthcare

Genetic resources, IP and benefits sharing: what changes are ahead internationally?

The WIPO has set out disclosure rules for patent applications as the UN pushes for sharing digital sequence information

13/02/2025

Read time 5m

Life Sciences and Healthcare

Streamlined reimbursement law looks to boost medicine access in Poland

What can Poland's pharmaceutical industry expect from further reforms due in the second quarter of this year?

07/02/2025

Read time 2m

View all insights

Life Sciences and Healthcare

Court of Appeal overturns English Patents Court and grants interim injunction to prevent 'at risk' generic launch

Patents Court found wrong to hold damages would be an adequate remedy for AstraZeneca

29/04/2025

Read time 6m

Life Sciences and Healthcare

EU court issues significant decision on pharma-device 'borderline' product case

European ruling clarifies the definition of pharmacological action for health products

24/04/2025

Read time 4m

Intellectual property

European Council adopts negotiating mandate on patents for gene-edited plants

EU moves closer to regulatory change for gene-edited plants but still a long way to go

16/04/2025

Read time 4m

Life Sciences and Healthcare

EU proposes tailored approach to streamline biosimilar development

New EMA reflection paper signals a step change in biosimilar approval, reducing requirements while maintaining standards

08/04/2025

Read time 3m

Life Sciences and Healthcare

New regulations signal next step for precision bred plants in England

Government sets out new simplified authorisation process for precision bred organisms

08/04/2025

Read time 3m

Regulatory and compliance

How is the UK regulatory landscape set to change?

The government is driving a pro-growth agenda, leading to transformative changes in regulatory operations

27/03/2025

Read time 12m

Life Sciences and Healthcare

EU set to upgrade medtech and diagnostics regulations

Commission-led targeted evaluation and reforms to the EU medical devices regulatory framework are reshaping the sector

25/03/2025

Read time 6m

Life Sciences and Healthcare

EU regulatory activity is driving comprehensive reforms for pharma in 2025

The European Union's regulatory framework for the pharmaceutical sector is undergoing significant transformations

25/03/2025

Read time 5m

Commercial

New EU packaging and waste regulation comes into force to promote sustainability

Effective implementation of this advance for the circular economy now depends on national legislation by Member States

25/02/2025

Read time 3m

Regulatory and compliance

Court of Appeal rules on duty to clarify tender submissions with bidders in UK public procurement

Decision explains when contracting authorities must clarify incomplete or ambiguous information in tender submissions

21/02/2025

Read time 7m

Life Sciences and Healthcare

The fight against counterfeit medicines in Italy

The Italian legislative decree implementing Regulation (EU) 2016/161 enters into force

20/02/2025

Read time 3m

Life Sciences and Healthcare

The Future of Cannabis in Germany: What to Expect After the 2025 Elections

The German cannabis industry is transforming rapidly. The introduction of the Cannabis Act (CanG) in April 2024 brought significant changes...

19/02/2025

Read time 3m

Regulatory and compliance

New NPPS sets out 'value for money' message for UK public procurement

Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability

14/02/2025

Read time 4m

Life Sciences and Healthcare

Genetic resources, IP and benefits sharing: what changes are ahead internationally?

The WIPO has set out disclosure rules for patent applications as the UN pushes for sharing digital sequence information

13/02/2025

Read time 5m

Life Sciences and Healthcare

Streamlined reimbursement law looks to boost medicine access in Poland

What can Poland's pharmaceutical industry expect from further reforms due in the second quarter of this year?

07/02/2025

Read time 2m

View all insights

Will James

Partner, International Life Sciences and Healthcare Sector Co-Leader, UK

+44 207 105 7774 Email Will Full biog

Dr. Andrea Schmoll

Partner, International Life Sciences and Healthcare Sector Co-Leader, Germany

+49 221 5108 4260 Email Andrea Full biog

Thomas Devred

Partner, Head of Life Sciences and Healthcare - Paris, France

+ 33 1 84 82 41 06 Email Thomas Full biog

Silvia Steiner

Partner, Spain

+34 93 419 18 18 Email Silvia Full biog

Maria Grazia Medici

Partner, Head of Life Sciences & Healthcare, Italy

+39 06 3269 5015 Email Maria Grazia Full biog

Herke van Hulst

Partner, Advocaat, The Netherlands

+31 207 02 86 72 Email Herke Full biog

Catherine Wolfenden

Partner, Disputes & Risk Practice Group Head, UK

+44 117 917 3600 Email Catherine Full biog

Marcus Vass

Partner, Head of Digital Health, UK

UK +44 2071 057 634 Email Marcus Full biog

Rafael García del Poyo

Partner, Spain

+34 91 576 44 76 Email Rafael Full biog

Peter Rudd-Clarke

Partner, UK

+44 207 105 7315 Email Peter Full biog

Tim Harris

Partner, UK

+44 207 105 7144 Email Tim Full biog

Giulia Verusio

Senior Associate, Italy

+39 06 3269 5008 Email Giulia Full biog

J. Carlos Suarez

Counsel, Italy

+39 02 5413 1772 Email J. Carlos Full biog

David Haex

Co-Managing Partner, Belgium

+32 2 515 9322 Email David Full biog

Xavier Pican

Partner, IP/ IT, France

+33 1 84 82 45 88 Email Xavier Full biog

Julia Kaufmann, LL.M.

Partner, Germany

+49 89 5434 8068 Email Julia Full biog

Dr Flemming Moos

Partner, Specialist lawyer for IT law, Germany

+49 40 55436 4054 Email Flemming Full biog

Dr Tim Reinhard

Partner, Head of Intellectual Property Germany, Wirtschaftsmediator (MuCDR), Germany

+49 89 5434 8024 Email Tim Full biog

Dr Martin Sundermann

Partner, Wirtschaftsmediator (MuCDR), Germany

+49 89 5434 8026 Email Martin Full biog

Marie-Louise Weeda

Partner, Lawyer, The Netherlands

+31 207 02 86 98 Email Marie-Louise Full biog

Steve Wilson

Managing Partner, US

+1 917 545 3672 Email Steve Full biog

Jordi Casas

Co-Managing Partner, Spain

+34 93 419 18 18 Email Jordi Full biog

View all

Belgium

China

France

Germany

India

Italy

Poland

Singapore

Spain

Sweden

The Netherlands

UK

USA

Insights

Life Sciences and Healthcare

Article list

Connect with one of our experts

Sign up for our newsletter

Legal Notice